Abstract
Four novel nontuberculous mycobacteria were discovered from a historical strain collection at the International Reference Laboratory of Mycobacteriology at Statens Serum Institut in Copenhagen, Denmark. Phylogenetic analysis combining the 16S rrs, internal transcribed spacer and 23S rrl elements, as well as a single-copy core-gene (hsp65, rpoB+C, secA and tuf) analysis of these freeze-dried mycobacteria, clinically isolated from gastric lavage samples between 1948 and 1955, showed to be associated with type strains grouping within the Terra and Fortuitum-Vaccae clade. Phenotypic characteristics, biochemical properties and fatty acid and mycolic acid profiles supported the classification as novel strains. A genomic comparison to the closest related type strain was done by calculating average nucleotide identity and in silico DNA:DNA hybridization values, which showed 87.9% and 33.0% for Mu0050, 85.2% and 27.4% for Mu0053, 85.3% and 27.6% for Mu0083 and 93.3% and 50.1% for Mu0102, respectively. The names proposed for the new species are Mycobacterium wendilense sp. nov. (Mu0050T=ITM 501390T=CCUG 77525T), Mycobacterium burgundiense sp. nov. (Mu0053T=ITM 501391T=CCUG 77526T), Mycobacterium kokjensenii sp. nov. (Mu0083T=ITM 501392T=CCUG 77527T) and Mycobacterium holstebronense sp. nov. (Mu0102T=ITM 501393T=CCUG 77528T).
Keywords: Mycobacterium burgundiense sp. nov., Mycobacterium holstebronense sp. nov., Mycobacterium kokjensenii sp. nov., Mycobacterium wendilense sp. nov., nontuberculous mycobacteria, novel species, taxonomic description
Introduction
The genus Mycobacterium was first described in 1896 by Lehmann and Neumann based primarily on phenotypic characteristics, and today, the genus contains just over 190 species with validly published names according to The International Code of Nomenclature of Prokaryotes [1]. This genus, which includes Mycobacterium tuberculosis and Mycobacterium leprae that cause severe human diseases, also encompasses a diverse group of so-called nontuberculous mycobacteria (NTM) [2]. While the genus was split into five genera in 2018, recent genomic analysis has re-combined these back into a single genus, Mycobacterium [3,4].
Human NTM disease has been associated with immunosuppression or structural lung damage. However, in recent years, NTM diseases have been documented in several immunocompetent individuals. Furthermore, many studies report an increasing global trend in NTM cases [5]. NTM found in various environmental niches are considered ubiquitous opportunistic pathogens that are contagious through the ingestion of contaminated water or food, inhalation of aerosols or inoculation [5,7].
Laboratory-based identification of mycobacteria has traditionally involved biochemical tests, colony morphology and pigmentation, together with optimal growth conditions and growth rate classification. The Runyon classification originally categorized species into two main groups: rapid-growing mycobacteria, where visible colonies form within 7 days, and slow-growing mycobacteria, whose colonies become visible after more than 7 days of incubation [8]. Later studies have revealed distinct groupings within these two classes, leading to the addition of an intermediate growth rate category. For example, Mycobacterium heraklionense, identified in 2013, is classified with an intermediate growth rate, with colonies appearing between 5 and 15 days of incubation [9]. The development of high-performance liquid chromatography (HPLC) and matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) methods has later enabled identification with higher sensitivity, analysing species-specific lipid and mycolic acid profiles. Later implementation of 16S rRNA (Sanger) sequencing has been used for a more straightforward comparison of phylogenetic relationships between species [10]. A combination of increased access to diagnostics, better culture methods and advancements in DNA sequencing and routine laboratory techniques has led to a rise in microbiological isolation of NTM and the discovery of several novel NTM species [11,12]. Today, a combination of phenotypic and genotypic criteria, including growth rate, mycolic acid type, biochemical characteristics and whole-genome sequencing (WGS), are used to distinguish closely related species and identify novel ones [13].
Since 1948, the International Reference Laboratory of Mycobacteriology (IRLM) at Statens Serum Institut (SSI) in Copenhagen has maintained a collection of over 4000 mycobacterial isolates that have been lyophilized and frozen. This collection provides an extraordinary opportunity to gain new insights into the history and genetics of mycobacteria. A previous study of these historical strains revealed four novel NTM species candidates. These were clinically isolated from patients in Denmark from 1948 to 1955. The novel species differed from known NTM species, and their uniqueness was verified by WGS and subsequent core-gene phylogenetic analysis [14].
In the present study, we present these four novel Mycobacterium strains and provide their genotypic and phenotypic characteristics. The proposed names for the four strains, designated Mu0050, Mu0053, Mu0083 and Mu0102, are Mycobacterium wendilense sp. nov., Mycobacterium burgundiense sp. nov., Mycobacterium kokjensenii sp. nov. and Mycobacterium holstebronense sp. nov., respectively.
Isolate selection, clinical data and culturing
In the recorded metadata, all four mycobacterial isolates included in this study were designated ‘saprophyte’. They were all isolated from gastric lavages and collected from female patients born between 1905 and 1940 who lived in different provinces in Denmark at the time of collection (Table 1). The records received from tuberculosis (TB) sanatoria or hospital departments provided no further details on patients’ medical histories.
Table 1. Sample and patient information on the four mycobacterial isolates included in this study.
| Isolate | Sample information | Patient information | ||||
| Sample material | Sample received | Recorded designation | Year of birth | Sex | Province of residence | |
| Mu0050 | Gastric lavage | 29 July 1948 | Saprophyte | 1905 | F | North Jutland |
| Mu0053 | Gastric lavage | 18 March 1948 | Saprophyte | 1940 | F | Bornholm |
| Mu0083 | Gastric lavage | 14 November 1949 | Saprophyte | 1911 | F | Copenhagen City |
| Mu0102 | Gastric lavage | 3 June 1955 | Saprophyte | 1919 | F | West Jutland |
Each freeze-dried isolate was resuspended in Dubos medium and cultured for 2 weeks in mycobacteria growth indicator tubes (MGIT) containing Middlebrook 7H9 broth supplemented with 0.8 ml of Oleic Albumin Dextrose Catalase (OADC) at 37 °C using the BD BACTEC™ MGIT™ 960 Mycobacteria Culture System (BD Diagnostic Systems, Franklin Lakes, NJ, USA). Additionally, each isolate was grown on Löwenstein–Jensen (LJ) slant media (SSI Diagnostica, Hillerød, Denmark) at 35 °C. The live bacteria were handled in the biosafety level 3 laboratory at the IRLM. All four isolates grew successfully on both solid LJ slants and in liquid MGIT medium, and the presence of acid-fast rod-shaped bacilli was confirmed by Ziehl–Neelsen (ZN) and auramine–rhodamine staining, respectively.
Species identification and WGS
The initial screening for NTM species was conducted using the GenoType Mycobacterium CM (v2.0) and GenoType Mycobacterium AS (v1.0) line probe assays (LPA; Hain Lifescience, Nehren, Germany). Each assay was prepared according to the published heat inactivation and cell-lysis protocol [15]. The genus Mycobacterium was confirmed for all four isolates, but no specific NTM species could be identified through the LPA approach (Table 2).
Table 2. Species identification results from Hain Genotype CM/AS LPA and whole-genome comparison using ANI and dDDH values, between isolates and species representatives from the genus Mycobacterium.
| Isolate | Genotype CM/AS LPA | Genome identity (% to closest match) | ||||
| Species | CM/AS pattern | Mycobacterium type strain (DSM no.) | 16S rrs gene | ANI | dDDH | |
| Mu0050 | Mycobacterium sp. | 1–3/1–3 | M. chitae (44633T) | 98.7 | 87.9 | 33.0 |
| Mu0053 | Mycobacterium sp. | 1–3/1–3 | M. chitae (44633T) | 98.0* | 85.2 | 27.4 |
| Mu0083 | Mycobacterium sp. | 1–3,10/1–3,12 | M. heraklionense (46753T) | 99.5* | 85.4 | 28.1 |
| Mu0102 | Mycobacterium sp. | 1–3,10/1–3,12 | M. virginiense (100883T) | 99.7* | 93.3 | 50.1 |
*A better 16S rRNA blast hit was found for these isolates than the highest ANI-scoring isolate (Mu0053: M. confluentis=98.4%, Mu0083: M. virginiense=99.5%, Mu0102: M. icosomasiliensis=99.7%). See also Table S1.
To ensure sufficient amounts of DNA for WGS on the Oxford Nanopore Technologies (ONT) platform, each isolate was cultured in four MGIT tubes. The bacteria were collected, and DNA was extracted using the QIAamp® DNA Mini Kit, as previously described [14], with the following modification: after the ethanol precipitation step, 600 µl aliquots of supernatant from all four extractions were added to the same spin column, before continuing to the washing steps, to increase the amount of DNA per isolate in the final eluate. Sequencing libraries were prepared using the Native barcoding genomic DNA kit (with EXP-NBD104, EXP-NBD114 and SQK-LSK109; ONT, Oxford, UK) according to the manufacturer’s protocol (version NBE_9065_v109_revV_14Aug2019) using AMPure XP beads (Beckman Coulter) for the clean-up steps. Purified libraries were run on a single FLO-MIN106D flow cell, and raw ONT reads were generated using the guppy base-calling software (v3.6.0). Subsequently, NanoFilt (v2.0.0) was used to remove reads with an average quality score below Q7, and the remaining barcode and adapter fragments were removed using qcat (v1.1.0). De novo genome assembly was performed using the Flye assembler (v.2.7.1), with three read polishing iterations and an expected final genome size of 5 Mb. The resulting contigs were imported into Geneious (v9.1.8) and marked as circular if indicated in the Flye assembler summary file. Previously generated paired-end Illumina reads [14] were imported and used to polish ONT-assembled draft genomes by mapping reads for up to five iterations, using the medium-low sensitivity setting in the built-in Geneious mapping module and to circularize any remaining open genomes. Consensus sequences were generated using a threshold of 75% and a minimum coverage threshold of 10 reads. Lastly, remaining variants and ambiguous base calls were manually resolved through visual inspection of both ONT and Illumina’s reads mapped to the new hybrid consensus. Thus, each strain genome sequence was consistently verified throughout by both ONT and Illumina sequences. Since these were obtained from separated cultures, they represent independent verifications of the genome. Coverage for each sequencing technology has been included in Table 3. We checked genome completeness with CheckM (v1.2.2), which showed 99.5–100% completeness for all genomes.
Table 3. Genome properties of completed genome sequences of four novel isolates, next to their closest related type strains (see Table 2). Secondary values in the Mu0050 column are for its plasmid genome. C: circular genome topology, ONT: Oxford Nanopore Technologies.
| Property | Mu0050 | Mu0053 | M. chitae | Mu0083 | M. heraklionense | Mu0102 | M. virginiense |
| Genome size (bp) | 5 224 726/23 059 | 5 453 374 | 5 461 769 | 4 341 397 | 5 061 737 | 4 794 273 | 4 980 142 |
| G+C content (%) | 68.6/64.6 | 67.7 | 69.0 | 68.6 | 68.0 | 67.5 | 67.5 |
| Topology | C / C | C | C | C | C | C | C |
| No. plasmids | 1 | – | – | – | – | – | – |
| Illumina coverage (X) | 115/385 | 92 | 86 | 77 | |||
| ONT coverage (X) | 90/256 | 86 | 94 | 90 | |||
| Est. plasmid copy number | 3 |
Each genome assembly was compared to all species-level representative genome assemblies of the family Mycobacteriaceae, registered in the National Center for Biotechnology Information (NCBI) RefSeq database on 9 June 2022. The programs FastANI (v1.35; https://github.com/ParBLiSS/FastANI) and the genome-to-genome distance calculator (v3.0; https://ggdc.dsmz.de) were used to calculate average nucleotide identity (ANI) and in silico/digital DNA:DNA hybridization (dDDH) values, respectively [16]. Furthermore, full-length (1521–1535 bp) 16S rRNA sequences from each genome sequence were extracted with barrnap (v0.9; https://github.com/tseemann/barrnap) and used to search against the NCBI 16S rRNA database (bacterial and archaeal sequences) with the blastn tool [17]. Each 16S rRNA fragment was also later verified (with Sanger sequencing) upon depositing isolates to the Belgian Coordinated Collections of Microorganisms (ITM) culture collection. With three of the four isolates, we found matches with higher nucleotide identity than the corresponding best ANI match. Furthermore, with the isolates Mu0083 and Mu0102, we found a number of 16S rRNA matches with >98.65% nucleotide identity, a commonly used species-level threshold for the 16S rRNA gene [18]. We therefore calculated dDDH values for each match to confirm that they each had lower values than the highest ANI matching species (Table S1, available in the online Supplementary Material). We observed that all high-scoring 16S rRNA matches fell below both species-level thresholds of 95% ANI and 70% dDDH, respectively. We therefore remained confident that all four isolates represent hitherto unknown species within the genus Mycobacterium [19]. Results for the four highest ANI-scoring species and their closest determined type strain have been included in Table 2.
Genome features
Complete genome annotation was performed using the NCBI Prokaryotic Genome Annotation Pipeline (PGAP; v5.2, build version: 2021-07-01.build5508; https://github.com/ncbi/pgap). We also used the PathogenFinder (v1.1) and ResFinder (v4.1) web services (http://www.genomicepidemiology.org/services) to assess pathogenicity and acquired antimicrobial resistance (AMR) from each genome sequence. All four isolates were predicted to be human pathogens by PathogenFinder due to the presence of pathogenic gene families, but no AMR genes were identified, indicating low intrinsic drug resistance. The estimated human pathogen probability scores (PPS) obtained for the proposed novel species revealed lower values for Mu0050 and Mu0053 (0.45 and 0.52, respectively) compared to Mu0083 and Mu0102 (0.66 and 0.85, respectively). The isolate with the highest PPS still exhibited a marginally lower score than known human pathogenic species of Mycobacterium such as tuberculosis, avium and intracellulare, which all scored over 0.95 when uploaded to PathogenFinder (data not shown). These results are summarized in Table 4.
Table 4. Annotation statistics of novel isolates, obtained using the NCBI PGAP, next to their closest related type strains (see Table 2). Values from type strains were obtained from NCBI RefSeq. PF: PathogenFinder, NA: Not available.
| Property | Mu0050 | Mu0053 | M. chitae | Mu0083 | M. heraklionense | Mu0102 | M. virginiense |
| CDS | 4916 | 5127 | 5182 | 3932 | 4632 | 4376 | 4611 |
| Pseudogenes | 78 | 73 | 79 | 38 | 66 | 48 | 59 |
| rRNA loci | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| tmRNA genes | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| tRNA genes | 46 | 48 | 46 | 46 | 47 | 46 | 46 |
| ncRNA genes | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| IS-elements | 71 | 41 | na | 11 | na | 14 | na |
| rrs Δ451–482* | Yes | Yes | Yes | No | No | No | No |
| Prophages | 1 | 3 | na | 1 | na | 0 | na |
| PF pathogen score | 0.521 | 0.448 | 0.440 | 0.663 | 0.591 | 0.848 | 0.757 |
Similar to the pathogen scores, the annotation statistics reveal a pairwise heterogeneity, with the largest correlation observed between Mu0050 and Mu0053, as well as Mu0083 and Mu0102, respectively. Similar observations were made with genome size and G+C content, but all observed values were consistent with members of Mycobacterium, with Mu0083 and Mu0102 showing similarities to the type strains belonging to the Mycobacterium terrae complex, which are characterized by relatively smaller genome sizes [20]. Additionally, a 23 Kbp circular plasmid with an estimated copy number of 3 was identified in the isolate Mu0050 (Table 3).
We also observed a similar pairing when looking at annotation statistics (number of coding sequences, pseudogenes, etc.). The 16S rRNA sequences of Mu0050 and Mu0053 both lacked the short 12–14 nucleotide insert in helix 18 between positions 451 and 482, whereas the 16S rRNA sequences of Mu0083 and Mu0102 contained the extended helix at the same position (Table 4). This deletion in rrs 451–482 is well-characterized and often used as a marker to distinguish between rapid- and slow-growing mycobacteria [4,21].
Phylogeny
To determine the evolutionary placement of the four new isolates within the genus Mycobacterium, we generated a phylogeny using a subset of 44 reference genomes, which we selected based on an 80% ANI cutoff. This approach reduced computational complexity while adequately representing the most closely related species. Additionally, Mycobacterium abscessus was included to act as an outgroup. Due to the relatively poor discriminatory power of the 16S rRNA gene within the genus Mycobacterium, we elected to use the complete 16S–23S rDNA region, including the internal transcribed spacer (ITS) [22]. Sequences were first aligned using the software MAFFT, manually checked and curated for poorly aligned regions in Geneious. We then used IQ-tree to perform phylogenetic analysis [23]. The alignment was partitioned into 16S rrs, ITS and 23S rrl regions. ModelFinder was used to select the best-fit model of sequence evolution of each respective region according to the Bayesian information criterion. Ultrafast bootstrap analysis with 1000 replicates was conducted to generate a consensus tree with a 90% bootstrap support cutoff, which we visualized using the iTOL web service (Fig. 1a). From this consensus tree, we identified two robust clades, one containing the isolates Mu0050 and Mu0053 (corresponding to the ‘Fortuitum-Vaccae’ clade described by Gupta et al.) and one containing Mu0083 and Mu00102 (corresponding to the ‘Terrae’ clade) [4]. Each clade was subsequently analysed separately in the following manner for increased robustness: from each genome sequence, we extracted the five core genes hsp65, rpoB, rpoC, secA and tuf, each known to have relatively high discriminatory power within the genus Mycobacterium. We then employed a codon-based alignment approach, where sequences from each gene were translated into protein sequences, aligned using MAFFT and back-translated into their original DNA sequences to retain codon positions. The five alignments were then concatenated into one. We then used a partitioning model, where each gene was analysed separately, and first and second codon positions were evaluated separately from third codon positions to account for different rates of evolution. We then used IQ-tree with ModelFinder as described above, using ultrafast bootstrap and the SH-like approximate likelihood ratio test with 1000 replicates to calculate branch support values. The resulting two maximum likelihood phylogenies are shown in Fig. 1b. As expected, these phylogenies provided a more robust and detailed overview of species relation than the rrs–ITS–rrl rRNA region [24]. The two Terrae clade members were more closely related to surrounding type strains than the Fortuitum-Vaccae clade members (Mu0050 and Mu0053). However, the novel isolates (Mu0083 and Mu0102) showed clear separation with strong branch support, consistent with their novel species status based on below-threshold ANI and dDDH values, highlighting the limited discriminatory power of the 16S rRNA gene (see Tables 2 and S1).
Fig. 1. Maximum likelihood (ML) phylogenies of the four novel strains (Mu0050, Mu0053, Mu0083 and Mu0102), together with 44 selected reference genomes (80% ANI cutoff) generated using IQ-tree. The left tree (a) is a consensus tree of 1000 bootstrap replicates, based on the entire rDNA locus (16S rrs, ITS and 23S rrl concatenated). Clades are coloured according to their taxonomic grouping within the genus Mycobacterium [4]. The two trees on the right (b) show separate ML phylogenies generated using five concatenated single-copy core genes (hsp65, rpoB +C, secA and tuf) for the Terrae (top) and Fortuitum-Vaccae (bottom) clades. GenBank accessions for each strain genome are written in parenthesis next to their respective isolate along with their proposed new species names.
Physiology and chemotaxonomy
The four strains were characterized by a panel of phenotypic and biochemical tests using methods described by Murray et al. [25], with cultures isolated from MGIT and LJ. All tests were conducted in duplicate, and only young cultures were harvested and used for downstream tests and analyses. Growth rate and temperature tests were performed on Middlebrook 7H10 (MB7H10) agar plates (SSI Diagnostica, Denmark) at 22, 31, 35, 37 and 42 °C (Table S2), whereas pigmentation and colony morphology were studied using LJ media. Visible colonies for Mu0050, Mu0083 and Mu0102 appeared within 7 days, classifying these strains as rapid-growing. In contrast, Mu0053 displayed an intermediate growth rate, with visible colonies appearing after 10 days. All strains exhibited optimal growth at 35–37 °C, while none could grow at 42 °C. Additionally, a test on 5% blood agar (SSI Diagnostica, Denmark) was performed, and for all four strains, colonies appeared within 5 to 8 days. On LJ media, colonies of strains Mu0050 and Mu0053 showed small, smooth colonies measuring 1–2 mm in diameter with a cream-coloured/light brown pigmentation, similar to their closest related reference M. chitae. In contrast, strain Mu0083 and Mu0102 colonies were rough and had yellow pigmentation. The colonies of Mu0083 were 1 mm and noticeably paler than the 2 mm big Mu0102. Both isolates showed physiological differences compared to their closest relative, for which pigmentation is described as absent and the colony morphology for M. heraklionense is smooth. The panel of recommended biochemical reactions included the following: catalase activity, Tween 80 hydrolysis, growth on MacConkey agar, nitrate reduction and activity of pyrazinamidase and urease (Table 5). None of the strains was positive for heat-stable catalase activity; however, in the semiquantitative catalase test, Mu0050 differed by showing limited effervescence (<45 mm). None of the novel strains could grow on MacConkey agar without crystal violet in the inhibition test, but all strains were positive in the nitrate reduction assay, distinguishing Mu0050 and Mu0053 from M. chitae. Mu0050 and Mu0053 were distinct from Mu0083 and Mu0102 in their ability to hydrolyse Tween 80, demonstrating negative and positive activity, respectively. All isolates were cultured in BACTEC MGIT 960 PZA medium (pH=5.9) to test for pyrazinamidase activity and growth at lower pH values (BD Diagnostic Systems, Franklin Lakes, NJ, USA). A loss of pyrazinamidase activity was observed in all novel strains (positive culturing within 7–10 days) except Mu0050, which, similar to M. chitae, showed susceptibility to the antimicrobial drug pyrazinamide. A comparison with the closest related and previously described NTM species is also detailed in Table 5.
Table 5. Growth characteristics and biochemical tests of the four novel isolates compared to their closest related species. Data for related species were retrieved from the following literature; M. chitae [31], M. heraklionense [9], M. virginiense [32]. Growth rates: Rapid, <7 days; Intermediate, 5–12 days; Slow, >12 days.
| Property | Mu0050 | Mu0053 | M. chitae | Mu0083 | M. heraklionense | Mu0102 | M. virginiense |
| Growth characteristics | |||||||
| Growth rate (days) | Rapid | Intermediate | Rapid | Rapid | Intermediate | Rapid | Slow |
| Optimal temperature (°C) | 35–37 | 35 | 28–37 | 35 | 25–37 | 37 | 35 |
| Growth at 42 °C | − | − | − | − | − | − | − |
| Pigmentation | Cream | Cream | Cream | Pale yellow | Absent | Yellow | Absent |
| Colony morphology | Smooth | Smooth | Smooth | Rough | Smooth | Rough | na |
| Biochemical tests | |||||||
| Catalase (68 °C) | + | + | + | + | + | + | + |
| Semi-quantitative catalase test | < 45 mm | > 45 mm | na | > 45 mm | > 45 mm | > 45 mm | > 45 mm |
| Growth on MacConkey agar | − | − | − | − | − | − | na |
| Nitrate reduction | + | + | − | + | + | + | + |
| Pyrazinamide | + | − | + | − | na | − | + |
| Tween 80 hydrolysis | − | − | na | + | + | + | + |
| Urease | − | − | + | − | − | − | − |
| Growth on blood agar | + | + | + | + | + | + | na |
Chemotaxonomy
HPLC was used to identify extracted mycolic acid patterns of the four novel strains using the protocol and instructions described by Hagen et al. and the Sherlock Mycobacteria Identification System (MIDI) [26]. Analyses were carried out on a Vanquish UHPLC system (Thermo Scientific) consisting of a quaternary pump (VF-P20-A), an autosampler with a thermostat and column compartment (VH-A10-A and VH-C10-A) and a fluorescence detector (VF-D50-A). The fluorometric detection wavelengths were set to 345 and 425 nm for emission and excitation, respectively. The data were acquired and processed using Chromeleon 7.2 SR4. Chromatographic separation was carried out on a Kromasil 100–5 C18 HPLC column with a particle size of 5 µm, dimensions 3.9×150 mm and used with a column temperature of 50 °C, an injection volume of 20 µl and an isocratic flow of 1.0 ml min−1 for 23 min per sample. Each sample was eluded with a gradient from 10% to 90% of methanol and 2-propanol. The HPLC chromatograms were prepared using Prism 9 (GraphPad Software, Inc.) (Fig. 2). Mycolic acid patterns for Mu0050 and Mu0053 were very similar to the pattern of reference strain M. chitae, the closest related species within previous analyses, providing two significant double peaks within one cluster eluting between 15 and 20 min (Figs 2 and S1). HPLC of Mu0083 and Mu0102 proved to be closest to the mycobacteria of the M. terrae complex, displaying two separate peak clusters as related species, as described by Butler et al. [27]. For Mu0083 and Mu0102, the clusters peaked between 10 and 13 min and again at 19.7 min (Fig. 2).
Fig. 2. Mycolic acid HPLC patterns of the four novel strains.
Duplicated MALDI-TOF mass spectrometry (MS) protein profiles for the four isolates were acquired using a Bruker Microflex LT/SH platform with the microbial identification software MALDI Biotyper® (MBT) Compass (v4.1). Cells were harvested from MGIT cultures, followed by inactivation and preparation according to the MALDI-TOF sonication protocol described by Alcaide et al. [28]. The MS profiles were obtained from technical duplicates and processed using Bruker Compass for the flexSeries 1.4 package, including flexAnalysis (v3.4) and flexControl (v3.4) software. MS spectra of the four strains did not match any spectral profiles of known mycobacteria included in the MBT Compass species identification programme. Nevertheless, they were assigned to the genus Mycobacterium and showed unique species-specific MS profiles (Fig. 3).
Fig. 3. MALDI-TOF MS spectra of the four strains.
Antimicrobial susceptibility testing
A phenotypic in vitro antimicrobial susceptibility testing (AST) of the four novel strains was performed using both Sensititre® RAPMYCO and SLOMYCO plates and panel test kits (TREK Diagnostic Systems, Thermo Scientific, Cleveland, OH, USA) according to the manufacturer’s protocol to get a broad panel of drug susceptibilities. This broth-based microdilution method was designed based on Clinical and Laboratory Standards Institute guidelines, including relevant NTM drug options [29]. The two strains, Mu0083 and Mu0102, could not grow within the SLOMYCO plates with the kit-included cation-adjusted Mueller–Hinton broth (MHB) added to the OADC buffer. However, successful growth in the SLOMYCO plates was achieved by using cation-adjusted MHB with N-Tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid (TES) buffer, which is provided for the RAPMYCO test kit. The minimal inhibitory concentrations (MICs) were read after 72 h of incubation at 37 °C. The testing for antimicrobial susceptibility also presented a pairwise concordance between the isolates Mu0050 and Mu0053, as well as Mu0083 and Mu0102, respectively (Table 6).
Table 6. AST showing MIC distributions of the novel strains Mu0050, Mu0053, Mu0083 and Mu0102 using TREK Sensititre® RAPMYCO and SLOMYCO plates with TES medium.
| Drug | Mu0050 | Mu0053 | Mu0083 | Mu0102 |
| SXT | 1/19 | 4/76 | >8/152 | >8/152 |
| CIP | ≤0.12 | ≤0.12 | 4 | 1 |
| MXF | ≤0.12 | ≤0.12 | 4 | 1 |
| FOX | 64 | 64 | >128 | >128 |
| AMI | ≤1 | ≤1 | 4 | 4 |
| DOX | 0.5 | 0.5 | 16 | 8 |
| TGC | 0.25 | 1 | >4 | >4 |
| CLA | 64 | >64 | 0.25 | >64 |
| LZD | 4 | 2 | 4 | 2 |
| IMI | 64 | >64 | >64 | >64 |
| FEP | >32 | >32 | >32 | >32 |
| AUG2 | 64/32 | >64/32 | >64/32 | >64/32 |
| AXO | 32 | >64 | 16 | 16 |
| MIN | ≤1 | ≤1 | >8 | >8 |
| TOB | 4 | 2 | ≤1 | ≤1 |
| RFB | 0.5 | 4 | ≤0.25 | ≤0.25 |
| EMB | 4 | 4 | >16 | >16 |
| INH | >8 | >8 | >8 | >8 |
| RIF | >8 | >8 | ≤0.12 | ≤0.12 |
| STR | 2 | 1 | 64 | 32 |
| ETH | >20 | >20 | >20 | >20 |
Discussion
This study introduces four new NTM species identified from the historical strain collection maintained at the IRLM at SSI, Copenhagen, since 1948. The unnamed species were isolated in the 1950s from pulmonary samples derived from patients, most likely under suspicion of TB. Unfortunately, due to a lack of detailed medical history, it remains unclear whether the identified NTM were the cause of lung disease, indicators of NTM colonization or simply transient findings. Nonetheless, given that pulmonary samples were procured from either TB sanatoria or hospital departments, we can presume the presence of TB-like symptoms in all four cases.
Our genomic analysis identified the three nearest known species to our novel strains: M. chitae for Mu0050 and Mu0053, M. heraklionense for Mu0083 and M. virginiense for Mu0102. These related mycobacteria fall into one out of four risk groups, based on their clinical relevance for humans and animals, according to European Union Directive 2000/54/EC. All three closest relatives to the novel species (M. chitae, M. heraklionense and M. virginiense) are assigned to group 2, which can cause illness but are unlikely to spread to the community and are usually treatable [30].
While categorizing these closely related species into risk group 2 matches their known low clinical significance, our PathogenFinder analysis predicts pathogenicity for each of the four novel species. Notably, Mu0083 and Mu0102 had higher scores when predicting pathogenicity than Mu0050 and Mu0053. Despite being isolated from patients presumably presenting with pulmonary TB-like symptoms, their clinical relevance remains uncertain. Therefore, thorough descriptions of these novel NTM are essential for future accurate species identification and for establishing robust epidemiological relationships.
Throughout our analyses, we noticed a trend of pairwise correlation between Mu0050 and Mu0053 and Mu0083 and Mu0102. However, despite these relationships, each of the four isolates represents distinct species, as their physiological and chemotaxonomic properties, mycolic acid and lipid profiles and phylogenetic placement attest. Therefore, these four historical mycobacterial strains each represent novel species of the genus Mycobacterium.
Protologue
Description of Mycobacterium wendilense sp. nov.
Mycobacterium wendilense (wen.di.len’se. M.L. neut. adj. wendilense, of Vendsyssel in the northern Jutland, Denmark, where the patient lived).
A non-motile, acid-fast, rod-shaped, Gram-positive and fast-growing bacterium. Growth on solid media requires culturing for <7 days at temperatures between 31 and 37 °C, optimally at 35 °C, producing small, smooth, cream-coloured colonies of 1–2 mm in diameter on Middlebrook 7H10 agar plates. This species produces <45 mm foam in the semiquantitative catalase test, is positive for heat-stable catalase and exhibits nitrate reduction. Reactions for urease activity and Tween 80 hydrolysis were negative, and no growth was attained when culturing at 42 °C nor on MacConkey agar without crystal violet.
The genome of type strain Mu0050T (= ITM 501390T = CCUG 77525T) comprises 5 224 726 bp in silico, and the G+C content is 68.6%. The whole-genome sequence and the 16S rRNA gene sequence are deposited in the NCBI GenBank database under the accession numbers GCA_963378085.1 and PP499327, respectively.
Description of Mycobacterium burgundiense sp. nov.
Mycobacterium burgundiense (bur.gun.di.en’se. N.L. neut. adj. burgundiense, named after the island Bornholm – in Latin: Burgundia, where the patient lived in a small village).
The non-motile, acid-fast, rod-shaped and Gram-positive bacterium is growing at an intermediate rate. Growth on solid media requires culturing for >9 days at temperatures between 22 and 37 °C, optimally at 35 °C, producing small, smooth, light brown coloured colonies of 1–2 mm in diameter on Middlebrook 7H10 agar plates. This species produces >45 mm foam in the semiquantitative catalase test, is positive for heat-stable catalase and exhibits nitrate reduction. Reactions for urease activity and Tween 80 hydrolysis were negative, and no growth was attained when culturing at 42 °C nor on MacConkey agar without crystal violet.
The genome of type strain Mu0053T (= ITM 501391T = CCUG 77526T) comprises 5 453 374 bp in silico, and the G+C content is 67.7%. The whole-genome sequence and the 16S rRNA gene sequence are deposited in the NCBI GenBank database under accession numbers GCA_963378095 and PP499328, respectively.
Description of Mycobacterium kokjensenii sp. nov.
Mycobacterium kokjensenii (kok.jen.se’ni.i. N.L. gen. n. kokjensenii, is named after Axel Kok-Jensen, a Danish pulmonologist who dedicated his life to combating lung diseases, particularly with a focus on mycobacteria and TB among socially disadvantaged population groups in Denmark).
A non-motile, acid-fast, rod-shaped, Gram-positive and fast-growing bacterium. Growth on solid media requires culturing for <7 days at temperatures between 22 and 37 °C, optimally at 35 °C, producing small, rough, pale yellow-coloured colonies of 1 mm in diameter on Middlebrook 7H10 agar plates. This species produces >45 mm foam in the semiquantitative catalase test, is positive for heat-stable catalase and exhibits nitrate reduction. Reactions for urease activity and Tween 80 hydrolysis were negative, and no growth was attained when culturing at 42 °C nor on MacConkey agar without crystal violet.
The genome of type strain Mu0083T (= ITM 501392T = CCUG 77527T) comprises 4 341 397 bp in silico, and the G+C content is 68.6%. The whole-genome sequence and the 16S rRNA gene sequence are deposited in the NCBI GenBank database under accession numbers GCA_963378075 and PP499329, respectively.
Description of Mycobacterium holstebronense sp. nov.
Mycobacterium holstebronense (hol.ste.bro.nen’se. N.L. neut. adj. holstebronense, Holstebro, Denmark, referring to the place of isolation at the TB sanatorium in Holstebro, 1955).
A non-motile, acid-fast, rod-shaped, Gram-positive and fast-growing bacterium. Growth on solid media requires culturing for <7 days at temperatures between 22 and 37 °C, optimally at 37 °C, producing small, rough, yellow-coloured colonies of 2 mm in diameter on Middlebrook 7H10 agar plates. This species generates >45 mm of foam in the semiquantitative catalase test, tests positive for heat-stable catalase and demonstrates nitrate reduction and Tween 80 hydrolysis. Urease activity was negative, and the species failed to grow at 42 °C or on MacConkey agar without crystal violet.
The genome of type strain Mu0102T (= ITM 501393T = CCUG 77528T) comprises 4 794 273 bp in silico, and the G+C content is 67.5%. The whole-genome sequence and the 16S rRNA gene sequence are deposited in the NCBI GenBank database under accession numbers GCA_963378105 and PP499330, respectively.
Repositories
| Isolate | Assembly id | Study id | Sample id | GenBank id | 16S rRNA id |
| Mu0050 | GCA_963378085.1 | PRJEB50291 | ERS16256601 | OY726395 | PP499327 |
| Plasmid (pMu0050) | OY726396 | ||||
| Mu0053 | GCA_963378095 | PRJEB50291 | ERS16256603 | OY726397 | PP499328 |
| Mu0083 | GCA_963378075 | PRJEB50291 | ERS16256605 | OY726394 | PP499329 |
| Mu0102 | GCA_963378105 | PRJEB50291 | ERS16256607 | OY726398 | PP499330 |
supplementary material
Acknowledgement
The authors thank Søren Overballe-Petersen and Rasmus Krøger Hare at the Department of Bacteria, Parasites and Fungi, SSI, Copenhagen, for support and analytical assistance regarding ONT MinION and MALDI-TOF, respectively, and Leen Rigouts at the Mycobacteriology/Institute of Tropical Medicine (ITM), Antwerp, Belgium, for providing the ribosomal 16S rRNA Sanger sequences.
Abbreviations
- aLRT
approximate likelihood ratio test
- AMR
antimicrobial resistance
- ANI
average nucleotide identity
- AST
antimicrobial susceptibility testing
- BiC
Bayesian information criterion
- CDS
protein-coding sequence
- CLSI
Clinical and Laboratory Standards Institute
- GGD
genome-to-genome distance
- HPLC
high-performance liquid chromatography
- IRLM
International Reference Laboratory of Mycobacteriology
- ITS
internal transcribed spacer
- LJ
Löwenstein–Jensen
- LPA
line probe assay
- MALDI-TOF
matrix-assisted laser desorption ionization-time of flight
- MB7H10
Middlebrook 7H10
- MBT
MALDI Biotyper®
- MGIT
mycobacteria growth indicator tube
- MHB
Mueller–Hinton broth
- MIC
minimal inhibitory concentrations
- MS
mass spectrometry
- NCBI
National Center for Biotechnology Information
- NTM
nontuberculous mycobacteria
- ONT
Oxford Nanopore Technologies
- PGAP
Prokaryotic Genome Annotation Pipeline
- PPS
pathogen probability scores
- SSI
Statens Serum Institut
- TB
tuberculosis
- TES
N-Tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid
- WGS
whole-genome sequencing
- ZN
Ziehl–Neelsen
Footnotes
Funding: This study was performed at the International Reference Laboratory of Mycobacteriology, Statens Serum Institut, Copenhagen, and was partially supported by the Independent Research Fund Denmark (grant no. 3127-00035B).
Contributor Information
Xenia Emilie Sinding Iversen, Email: xesi@ssi.dk.
Erik Michael Rasmussen, Email: mre@ssi.dk.
Dorte Bek Folkvardsen, Email: dbe@ssi.dk.
Erik Svensson, Email: esn@ssi.dk.
Conor J. Meehan, Email: conor.meehan@ntu.ac.uk.
René Jørgensen, Email: renejoe@ruc.dk.
Anders Norman, Email: ansm@ssi.dk.
Troels Lillebaek, Email: tll@ssi.dk.
References
- 1.Parte AC, Sardà Carbasse J, Meier-Kolthoff JP, Reimer LC, Göker M. List of prokaryotic names with standing in nomenclature (LPSN) moves to the DSMZ. Int J Syst Evol Microbiol. 2020;70:5607–5612. doi: 10.1099/ijsem.0.004332. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Opperman CJ, Singh S, Davids T, Cox H, Warren R, et al. Identifying non-tuberculosis mycobacteria: is it time to introduce new molecular assays? S Afr Med J. 2023;113:4–5. doi: 10.7196/SAMJ.2022.v113i6.16771. [DOI] [PubMed] [Google Scholar]
- 3.Meehan CJ, Barco RA, Loh Y-H, Cogneau S, Rigouts L. Reconstituting the genus Mycobacterium. Int J Syst Evol Microbiol. 2021;71 doi: 10.1099/ijsem.0.004922. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Gupta RS, Lo B, Son J. Phylogenomics and comparative genomic studies robustly support division of the genus Mycobacterium into an emended genus Mycobacterium and four novel genera. Front Microbiol. 2018;9:67. doi: 10.3389/fmicb.2018.00067. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Dahl VN, Mølhave M, Fløe A, van Ingen J, Schön T, et al. Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review. Int J Infect Dis. 2022;125:120–131. doi: 10.1016/j.ijid.2022.10.013. [DOI] [PubMed] [Google Scholar]
- 6.Seth-Smith HMB, Imkamp F, Tagini F, Cuénod A, Hömke R, et al. Discovery and characterization of Mycobacterium basiliense sp. nov., a nontuberculous Mycobacterium isolated from human lungs. Front Microbiol. 2018;9:3184. doi: 10.3389/fmicb.2018.03184. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Ghielmetti G, Rosato G, Trovato A, Friedel U, Kirchgaessner C, et al. Mycobacterium helveticum sp. nov., a novel slowly growing mycobacterial species associated with granulomatous lesions in adult swine. Int J Syst Evol Microbiol. 2021;71:ijsem004615. doi: 10.1099/ijsem.0.004615. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Runyon EH. Identification of mycobacterial pathogens utilizing colony characteristics. Am J Clin Pathol. 1970;54:578–586. doi: 10.1093/ajcp/54.4.578. [DOI] [PubMed] [Google Scholar]
- 9.Tortoli E, Gitti Z, Klenk H-P, Lauria S, Mannino R, et al. Survey of 150 strains belonging to the Mycobacterium terrae complex and description of Mycobacterium engbaekii sp. nov., Mycobacterium heraklionense sp. nov. and Mycobacterium longobardum sp. nov. Int J Syst Evol Microb. 2013;63:401–411. doi: 10.1099/ijs.0.038737-0. [DOI] [PubMed] [Google Scholar]
- 10.Ohta M, Pan YT, Laine RA, Elbein AD. Trehalose-based oligosaccharides isolated from the cytoplasm of Mycobacterium smegmatis. relation to trehalose-based oligosaccharides attached to lipid. Eur J Biochem. 2002;269:3142–3149. doi: 10.1046/j.1432-1033.2002.02971.x. [DOI] [PubMed] [Google Scholar]
- 11.van Ingen J, Bendien SA, de Lange WCM, Hoefsloot W, Dekhuijzen PNR, et al. Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands. Thorax. 2009;64:502–506. doi: 10.1136/thx.2008.110957. [DOI] [PubMed] [Google Scholar]
- 12.Liu G, Yu X, Luo J, Hu Y, Dong L, et al. Mycobacterium vicinigordonae sp. nov., a slow-growing scotochromogenic species isolated from sputum. Int J Syst Evol Microbiol. 2021;71 doi: 10.1099/ijsem.0.004796. [DOI] [PubMed] [Google Scholar]
- 13.Nouioui I, Sangal V, Carro L, Teramoto K, Jando M, et al. Two novel species of rapidly growing mycobacteria: Mycobacterium lehmannii sp. nov. and Mycobacterium neumannii sp. nov. Int J Syst Evol Microb. 2017;67:4948–4955. doi: 10.1099/ijsem.0.002350. [DOI] [PubMed] [Google Scholar]
- 14.Iversen XES, Norman A, Folkvardsen DB, Svensson E, Rasmussen EM, et al. Successful direct whole genome sequencing and revivification of freeze-dried nontuberculous mycobacteria after more than half a century of storage. Microbiol Spectr. 2022;10:e0031022. doi: 10.1128/spectrum.00310-22. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Bjorn-Mortensen K, Zallet J, Lillebaek T, Andersen AB, Niemann S, et al. Direct DNA extraction from Mycobacterium tuberculosis frozen stocks as a reculture-independent approach to whole-genome sequencing. J Clin Microbiol. 2015;53:2716–2719. doi: 10.1128/JCM.00662-15. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Meier-Kolthoff JP, Carbasse JS, Peinado-Olarte RL, Göker M. TYGS and LPSN: a database tandem for fast and reliable genome-based classification and nomenclature of prokaryotes. Nucleic Acids Res. 2022;50:D801–D807. doi: 10.1093/nar/gkab902. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol. 1990;215:403–410. doi: 10.1016/S0022-2836(05)80360-2. [DOI] [PubMed] [Google Scholar]
- 18.Kim M, Oh HS, Park SC, Chun J. Towards a taxonomic coherence between average nucleotide identity and 16S rRNA gene sequence similarity for species demarcation of prokaryotes. Int J Syst Evol Microbiol. 2014;64:346–351. doi: 10.1099/ijs.0.059774-0. [DOI] [PubMed] [Google Scholar]
- 19.Tortoli E, Meehan CJ, Grottola A, Fregni Serpini G, Fabio A, et al. Genome-based taxonomic revision detects a number of synonymous taxa in the genus Mycobacterium. Infect Genet Evol. 2019;75:103983. doi: 10.1016/j.meegid.2019.103983. [DOI] [PubMed] [Google Scholar]
- 20.Fedrizzi T, Meehan CJ, Grottola A, Giacobazzi E, Fregni Serpini G, et al. Genomic characterization of nontuberculous mycobacteria. Sci Rep. 2017;7:45258. doi: 10.1038/srep45258. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Hashemi-Shahraki A, Bostanabad SZ, Heidarieh P, Titov LP, Khosravi AD, et al. Species spectrum of nontuberculous mycobacteria isolated from suspected tuberculosis patients, identification by multi locus sequence analysis. Infect Genet Evol. 2013;20:312–324. doi: 10.1016/j.meegid.2013.08.027. [DOI] [PubMed] [Google Scholar]
- 22.Huang W-C, Yu M-C, Huang Y-W. Identification and drug susceptibility testing for nontuberculous mycobacteria. J Formos Med Assoc . 2020;119 Suppl 1:S32–S41. doi: 10.1016/j.jfma.2020.05.002. [DOI] [PubMed] [Google Scholar]
- 23.Nguyen L-T, Schmidt HA, von Haeseler A, Minh BQ. IQ-TREE: A fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies. Mol Biol Evol. 2015;32:268–274. doi: 10.1093/molbev/msu300. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Kim BJ, Lee SH, Lyu MA, Kim SJ, Bai GH, et al. Identification of mycobacterial species by comparative sequence analysis of the RNA polymerase gene (rpoB) J Clin Microbiol. 1999;37:1714–1720. doi: 10.1128/JCM.37.6.1714-1720.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Murray PAs. Manual of Clinical Microbiology, 7th ed. ASM Press; 1999. [Google Scholar]
- 26.Hagen SR, Thompson JD. Analysis of mycolic acids by high-performance liquid chromatography and fluorimetric detection implications for the identification of mycobacteria in clinical samples. J Chromatograph A. 1995;692:167–172. doi: 10.1016/0021-9673(94)00743-S. [DOI] [PubMed] [Google Scholar]
- 27.Butler WR, Guthertz LS. Mycolic acid analysis by high-performance liquid chromatography for identification of Mycobacterium species. Clin Microbiol Rev. 2001;14:704–726. doi: 10.1128/CMR.14.4.704-726.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Alcaide F, Amlerová J, Bou G, Ceyssens PJ, Coll P, et al. How to: identify non-tuberculous Mycobacterium species using MALDI-TOF mass spectrometry. Clin Microbiol Infect. 2018;24:599–603. doi: 10.1016/j.cmi.2017.11.012. [DOI] [PubMed] [Google Scholar]
- 29.CLSI . Susceptibility Testing of Mycobacteria, Nocardia Spp., and Other Aerobic Actinomycetes, 3rd edition. 3 ed: Clinical and Laboratory Standards Institute; 2018. [PubMed] [Google Scholar]
- 30.Pavlik I, Ulmann V, Hubelova D, Weston RT. Nontuberculous mycobacteria as sapronoses: a review. Microorganisms. 2022;10:1345. doi: 10.3390/microorganisms10071345. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31.Tsukamura M. Mycobacterium chitae: a new species. Jpn J Microbiol. 1967;11:43–47. doi: 10.1111/j.1348-0421.1967.tb00319.x. [DOI] [PubMed] [Google Scholar]
- 32.Vasireddy R, Vasireddy S, Brown-Elliott BA, Wengenack NL, Eke UA, et al. Correction for Vasireddy et al., Mycobacterium arupense, Mycobacterium heraklionense, and a newly proposed species, “Mycobacterium virginiense” sp. nov., but not Mycobacterium nonchromogenicum, as species of the Mycobacterium terrae complex causing tenosynovitis and osteomyelitis. J Clin Microbiol. 2017;55:985. doi: 10.1128/JCM.02290-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.



